Epidemiology of Bacteremia in Patients with Hematological Malignancies and Hematopoietic Stem Cell Transplantation and the Impact of Antibiotic Resistance on Mortality: Data from a Multicenter Study in Argentina
Pathogens · 26.10.2024 · 13 (11) · 933
DOI: 10.3390/pathogens13110933 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Pathogens, online erschienen am 26.10.2024. Verfasst von Fabián Herrera und 31 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Section, Internal Medicine Department, Centro de Educación Médica e Investigaciones Clínicas, (CEMIC), Buenos Aires C1431, Argent…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Bacteremia, Hematologic Neoplasms, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundación Dr. Norberto Quirno, Norberto Quirno Foundation (a non-profit organization) scholarship.
Abstract (Originalsprache)
The epidemiology of bacteremia and the antibiotic resistance profile (ARP) of Gram-negative bacilli (GNB) in hematological malignancies (HM) and hematopoietic stem cell transplant (HSCT) patients may differ according to geographic region. In addition, multidrug-resistant organisms (MDROs) may impact mortality. This is a prospective, observational, and multicenter study. The first episodes of bacteremia in adult patients with HM or HSCT were included. The risk factors for 30-day mortality were identified. One thousand two hundred and seventy-seven episodes were included (HM: 920; HSCT: 357). GNB were isolated in 60.3% of episodes, with Enterobacterales (46.9%) and P. aeruginosa (8.5%) being the most frequent. Gram-positive cocci were isolated in 41.9% of episodes, with coagulase-negative staphylococci (19.8%) and S. aureus (10.4%) being the most frequent. MDROs were isolated in 40.2% (24.4% GNB). The ARP of GNB in patients with HM vs. HSCT was cefepime: 36.8% vs. 45.7% (p = 0.026); piperacillin–tazobactam: 31.05% vs. 45.2% (p < 0.0001); carbapenems: 18.9% vs. 27.3% (p = 0.012); and aminoglycosides: 9.3% vs. 15.4% (p = 0.017), respectively. Overall mortality between patients with HM and HSCT was 17.5% vs. 17.6% (p = 0.951), respectively. The risk factors for mortality were relapsed and refractory underlying disease, corticosteroids use, respiratory source, septic shock, and GNB resistant to meropenem, while 7-day clinical response was a protective factor for survival. Bacteremia was frequently caused by GNB, with a large proportion of MDROs and a high level of antibiotic resistance, especially in patients with HSCT. Carbapenem-resistant GNB bacteremia was associated with a significant increase in mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Diseases Section, Internal Medicine Department, Centro de Educación Médica e Investigaciones Clínicas, (CEMIC), Buenos Aires C1431, Argentina.
- Infectious Diseases Service, Fundación para Combatir la Leucemia (FUNDALEU), Buenos Aires C1114, Argentina.
- Infectious Diseases Service, Hospital Británico de Buenos Aires, Buenos Aires C1280, Argentina.
- Infectious Diseases Service, Hospital Interzonal General de Agudos (HIGA) Dr. Rodolfo Rossi, La Plata B1902, Argentina.
- Infectious Diseases Service, Hospital Interzonal General de Agudos (HIGA) Gral. San Martín, La Plata B1900, Argentina.
- Infectious Diseases Section, Internal Medicine Department, Hospital Italiano de Buenos Aires, Buenos Aires C1199, Argentina.
ORCID-Profile: Diego Torres, Inés Roccia Rossi, Noelia Mañez, Lucas Tula, Andrea Nenna, Fernando Pasterán
Förderung
- Fundación Dr. Norberto Quirno
- Norberto Quirno Foundation (a non-profit organization) scholarship
Zitieren
APA
Herrera, F., Torres, D., Laborde, A., Jordán, R., Berruezo, L., Roccia Rossi, I., Mañez, N., Tula, L., Pereyra, M. L., Nenna, A., Costantini, P., Benso, J., González Ibañez, M. L., Eusebio, M. J., Baldoni, N., Barcán, L. A., Lambert, S., Luck, M., Pasterán, F., …, & Argentine Group for the Study of Bacteremia in Cancer and Stem Cell Transplant (ROCAS) (2024). Epidemiology of Bacteremia in Patients with Hematological Malignancies and Hematopoietic Stem Cell Transplantation and the Impact of Antibiotic Resistance on Mortality: Data from a Multicenter Study in Argentina. Pathogens, 13(11), 933. https://doi.org/10.3390/pathogens13110933
Vancouver
Herrera F, Torres D, Laborde A, Jordán R, Berruezo L, Roccia Rossi I, et al. Epidemiology of Bacteremia in Patients with Hematological Malignancies and Hematopoietic Stem Cell Transplantation and the Impact of Antibiotic Resistance on Mortality: Data from a Multicenter Study in Argentina. Pathogens. 2024;13(11):933. doi:10.3390/pathogens13110933
BibTeX
@article{Herrera2024,
author = {Herrera, Fabián and Torres, Diego and Laborde, Ana and Jordán, Rosana and Berruezo, Lorena and Roccia Rossi, Inés and Mañez, Noelia and Tula, Lucas and Pereyra, María Laura and Nenna, Andrea and Costantini, Patricia and Benso, José and González Ibañez, María Luz and Eusebio, María José and Baldoni, Nadia and Barcán, Laura Alicia and Lambert, Sandra and Luck, Martín and Pasterán, Fernando and Corso, Alejandra and Rapoport, Melina and Nicola, Federico and García Damiano, María Cristina and Monge, Renata and Carbone, Ruth and Reynaldi, Mariana and Greco, Graciela and Blanco, Miriam and Chaves, María Laura and Bronzi, Marcelo and Carena, Alberto and Argentine Group for the Study of Bacteremia in Cancer and Stem Cell Transplant (ROCAS), Argentine Group for the Study of Bacteremia in Cancer and Stem Cell Transplant (ROCAS)},
title = {Epidemiology of Bacteremia in Patients with Hematological Malignancies and Hematopoietic Stem Cell Transplantation and the Impact of Antibiotic Resistance on Mortality: Data from a Multicenter Study in Argentina},
journal = {Pathogens},
year = {2024},
volume = {13},
number = {11},
pages = {933},
doi = {10.3390/pathogens13110933}
}
EUVIMED